Gasteroenterologists 2020 | Rome | Italy | Allied Conferences | Meetings

Global assembling of Academicians, Researchers, Scholars & Industry to disseminate and exchange information at 100+ Allied Academies Conferences

Theme

Advances in Gastroenterology and Digestive Disorders

- Gasteroenterologists 2020

About Conference

Gastroenterology and Digestive Disorders 2021 is a one-of-a-kind conference that aims to discuss and generate new ideas for researchers in the field of gastroenterology. The conference brings together some of the latest and most fascinating research from around the world. Scientists and doctors from all around the world can exchange ideas, share discoveries, and discuss future collaborative initiatives in small and intimate settings. This will result in a larger worldwide learning base and spectacular advancements in the field of gastroenterology. This webinar features well-known presenters, cutting-edge techniques, and the most up-to-date information in the field.

Gastroenterologits2021 mainly deals with the Clinical Research Advancements in Gastroenterology, Endoscopy, Hepatology, Therapeutic Advancements, for gastrointestinal diseases, Geriatric Gastroenterology, Gastrointestinal motility, gastrointestinal hormones, colon cancer, pancreatic and biliary disease, Liver transplant techniques, and Entrepreneur’s investments in this field.

Why attend?

To meet and greet the medical specialty (Gastroenterology) Professionals from all over the world, that concentrate on gastrointestinal disorders and their advances, typically this can be often the golden chance to attain the foremost necessary gathering of all the professionals from the GI department to conduct Spread information, presentations, meeting with upcoming scientists, to acknowledge various researches within the sector, to interact with experienced professionals for better research and create a mark with new innovations at intervals within the sector of medical specialty and Liver diseases. To expertise the worldwide honored Speakers, to acknowledge latest techniques, developments, discoveries and latest updates at intervals the arena of medical specialty. pediatric & geriatric GI, cancer of the liver, Endoscopy, Gastric oncology, GIT Disorders during Pregnancy, Advances in Gastroenterology and Clinical researches in Gastroenterology, Advances in gastroenterology and Clinical researches in Gastroenterology is that the hallmarks of this Conference.

International conference on gastroenterology and digestive disorder scheduled as a webinar on December 17-18, 2021 is that the simplest platform to explore a lot of all the aspects of medical specialty and Hepatology as well as the analysis and research. Therefore, don’t miss the prospect to attend the December Conference.

Target audience:

· Gastroenterologists

· Hepatologists

· Oncologists

· Professors

· Doctors

· Scientists

· Endoscopists

· Anesthesiologists

· Gastro Surgeons

· Associate Professors

· Professor Emeritus

· Family Practitioners

· Gastroenterology Fellows

· Advanced Endoscopy Fellows

· Nurses

· Medical Equipment Manufacturers

· Clinical Development Physicians

· Distributors/Sales Representatives

· Pharmaceutical Companies

· Pharmaceutical Technology Specialist

· Endoscopy Technicians

· Medical Interns

· Physician Assistants

· Allied Health Professionals with an interest in Gastroenterology

· Radiologists

· Obesity Specialist

Welcome Message

It is our pleasure to welcome you all to the 3rd international conference on Gastroenterology and Digestive Disorders 2021. We are happy to welcome all participants on December 18, 2021 as a Webinar.

Gastro Summit 2021 brings upon a brand-new platform to share new ideas and discuss all the innovations within the field of medical specialty.

Meet our world specialists, eminent doctors, and speakers at our conference to talk regarding new advances in the medical specialty and biological process disorders to develop additional innovations that are introduced within the field of medical specialty. This will supply an excellent platform for researchers, students, hepatologists, Scientists, medical specialty, examination Specialists, Anesthesiologists, Professors, surgeons, Oncologists, Distributors or Sales Representatives, Pharmaceutical corporations, Medical Interns, Pharmaceutical Technology Specialist, examination Technicians to exhibit their work and acquire recognized amidst the foremost people.

We would want you all for this Gastro Summit 2021 to create brand new Innovations and technologies.

Sessions & Tracks

Track 1: Colorectal cancer/polyps

A colon polyp is a tiny cluster of cells that develops on the colon's lining. The majority of colon polyps are non-cancerous. However, some colon polyps can turn into colon cancer over time, which can be fatal if discovered in its later stages. Polyps in the colon don't always create symptoms. Regular screening tests, such as a colonoscopy, are necessary because colon polyps discovered early on can typically be safely and fully removed. Regular polyp detection and excision is the best way to avoid colon cancer.

Related Associations: World Gastroenterology Organization | American Gastroenterological Association | American Society for Gastrointestinal Endoscopy | American Association for the Study of Liver Diseases | The European Association for Gastroenterology, Endoscopy and Nutrition | The Society of Gastroenterology Nurses and Associates | Association of National European and Mediterranean Societies of Gastroenterology | European Society of Gastrointestinal Endoscopy.

Track 2: Endoscopy

A doctor can inspect the interior lining of the digestive tract through a procedure called gastrointestinal endoscopy. An endoscope is a flexible fiber-optic tube with a tiny TV camera at the end that is used for this examination. An upper GI endoscopy allows the examination of esophagus, stomach and duodenum. Ulcers, inflammations, and abnormalities in the colon can be diagnosed by colonoscopy. Enteroscopy can be utilized for analyzing the small bowel to detect GI bleeding, malabsorption and while performing surgeries.

Related Associations: European H. pylori Study Group | European Society of Neurogastroenterology and Motility | European Society of Coloproctology | European Pancreatic Club | European Society of Gastrointestinal and Abdominal Radiology | European Society of Digestive Oncology | European Society for Pediatric Gastroenterology, Hepatology and Nutrition | European Society for Primary Care Gastroenterology | The Japanese Society of Gastroenterology.

Track 3: Esophageal and gastric disease

Multiple diseases can be categorized under Esophageal and gastric disease. GERD, Hiatal Hernia, Barrett's Esophagus, and Achalasia are the most common. When stomach acid passes back into the tube that connects the mouth and stomach, it's called gastroesophageal reflux disease (GERD). This backwash (acid reflux) can cause irritation in the esophageal lining. Chronic inflammation in the esophagus can lead to esophageal stricture and esophageal ulcer.

Track 4: Hepatology

Owing to its focus on organs impacted by hepatic disorders, hepatology differs from other specialized disciplines of medicine. The liver, pancreas, gall bladder, and biliary tract comprise of the hepatic system. Because it involves portions of the gastrointestinal (GI) tract, Hepatology is associated to gastroenterology. Because both specialties include some of the same organs, hepatology is frequently considered a branch of gastroenterology. While a gastroenterologist can assist in the diagnosis and treatment of similar diseases, a hepatologist's focus is narrower.

Track 5: Pancreatic and biliary disease

The liver, pancreas, gallbladder, and/or bile ducts are all affected by pancreatic and biliary diseases. These disorders are frequently linked to long-term organ or surrounding tissue damage. These issues are sometimes genetically predetermined. These organs can create significant symptoms when they're in difficulty, but they can also cause problems quietly. Diseases with high statistics are acute pancreatitis, cholangitis, cholecytis, diabetes etc.

Track 6: Small bowel and colonic disease

A partial or total blockage of the small intestine is known as small intestinal obstruction. Digested items will continue to pass into the large intestine if the small bowel is working properly. A partial or total obstruction in the small bowel might prevent contents from going through. Waste materials and gases build up in the area above the blockage as a result. It may also prevent nutrients and fluids from being absorbed. The term "colonic illnesses" refers to conditions that affect the intestines. Irritable bowel illness (Crohn's disease and ulcerative colitis), Diverticular disease, and colon cancer are among the diseases covered under this field.

Track 7: Gastrointestinal hormones

Epithelial cells lining the lumen of the stomach and small intestine secrete the traditional GI hormones. Endocrinocytes, the hormone-secreting cells, are interspersed amid a considerably larger number of epithelial cells that discharge their products (acid, mucus, etc.) or draw up nutrients from the lumen. GI hormones are produced into the bloodstream and circulate throughout the body, influencing the operation of various portions of the digestive tract, the liver, the pancreas, the brain, and a variety of other organs. Hormones, neuropeptides, and neurotransmitters all have an influence on gastrointestinal function.

Track 8: Geriatric Gastroenterology

Patients over the age of 65 have a higher rate of esophageal and gastric diseases, including motility abnormalities, gastroesophageal reflux, reflux complications (such as Barrett's, dysplasia, and esophageal cancer), gastric ulcers, and gastrointestinal bleeding. Lower GI problems, such as pelvic floor abnormalities (including fecal incontinence), constipation, diarrheal illness, diverticular disease, inflammatory bowel disease, and colon cancer, also appear more frequently and atypically in the elderly. Malnutrition and obesity are major concerns among older adults, who have special dietary challenges.

Track 9: Inflammation and enteric infectious disease

Inflammation of the gastrointestinal tract is a complex biological response to harm caused by bacteria, damaged cells, or irritants. The symbiotic microbiome in the digestive tract is thought to protect the gut by eliminating unwanted stimuli and promoting recovery. Enteric dysfunction has been linked to malnutrition, delayed cognitive development, increased susceptibility to other infectious diseases, poor oral vaccine response, and increased mortality risk as a result of diarrheal disease, infections by parasites, alterations in the gut microbial environment, and other problems.

Track 10: Gastrointestinal Malignancy

The following are the most prevalent kinds of gastrointestinal cancers: Esophageal carcinoma, Gastric cancer (stomach cancer), colorectal cancer, pancreatic carcinoma and Liver cancer. Neuroendocrine tumors, gastrointestinal stromal tumors, and anal cancer are among the less prevalent forms. Tumors can also be caused by certain underlying disorders, such as esophageal reflux disease, Helicobacterpylori infection in the stomach, diabetes in the pancreas, inflammatory bowel disease in the large intestine (colon and rectum), hepatitis B or C virus infection, or liver cirrhosis. Inherited gastrointestinal malignancies account for a small percentage of all cancers.

Track 11: Gastrointestinal Motility

The flow of food from the mouth via the pharynx (throat), esophagus, stomach, small and large intestines, and out of the body is referred as gastrointestinal (GI) motility. Fasting (interdigestive) and postprandial (digestive) contraction patterns are two types of GI motility that changes with a meal. Contractility of the GI tract's smooth muscles, extrinsic and intrinsic neurons (motor and sensory), and certain hormones all influence GI motility. Ghrelin (GHRL) and motilin (MLN) promote hunger and GI motility in mammals and help to maintain energy homeostasis.

Track 12: Gastroenterology

The esophagus, stomach, small intestine, colon, and rectum, as well as the pancreas, gallbladder, bile ducts, and liver, are all studied in gastroenterology. It entails a thorough understanding of the gastrointestinal organs' normal function (physiology), which includes material movement through the stomach and intestine (motility), digestion and absorption of nutrients into the body, waste removal from the system, and the liver's role as a digestive organ. Colon polyps and cancer, hepatitis, gastroesophageal reflux disease (heartburn), peptic ulcer disease, colitis, gallbladder and biliary tract illness, nutritional issues, Irritable Bowel Syndrome (IBS), and pancreatitis are all included. In essence, Gastroenterology is the study of all normal and abnormal activities of the digestive organs.

Track 13: Digestive Disorders

Any health disorder that affects the digestive tract is referred to as a digestive ailment. Conditions may range from mild to serious. Functional and structural are the two types. The GI tract appears normal, but it does not function properly. It is functional illness. They are the most frequent gastrointestinal issues (including the colon and rectum). Common symptoms include constipation, irritable bowel syndrome (IBS), nausea, bloating, GERD, and diarrhea. The term "structural gastrointestinal illnesses" refers to conditions in which the colon looks odd and does not function properly. Surgical removal of the anomaly may be required. Strictures, stenosis, hemorrhoids, Diverticular disease, colon polyps, colon cancer, and inflammatory bowel disease are all instances of structural GI illnesses.

Track 14: Liver Transplant

A failing liver is removed and replaced with a healthy liver from a deceased donor or a piece of a healthy liver from a living donor during a liver transplant. A liver transplant is usually reserved for patients who are experiencing severe side effects from end-stage chronic liver disease. Acute or chronic liver failure is treated by transplantation.

Track 15: Hepatitis

Hepatitis is a liver infection that causes inflammation. Hepatitis is most commonly caused by a viral infection, although it can also be caused by other factors. Examples include atherosclerotic hepatitis and hepatitis caused by medications, drugs, toxins, or alcohol. Autoimmune hepatitis is a disease in which your body develops antibodies that damage the tissue of your liver. Hepatitis A, B, C, D, and E are viral illnesses of the liver that are classed as hepatitis. Hepatitis A is always an acute, short-term infection, but hepatitis B, C, and Dare more likely to become chronic and persistent. Hepatitis E is usually severe, but it can be very dangerous for pregnant women.

Market Analysis

The global gastrointestinal therapeutics market was worth USD 51.9 billion in 2016 and is expected to grow at a healthy CAGR of 6.6 percent over the next few years. The key driver of the market is the rising adoption of biologics for the treatment of gastrointestinal illnesses. Between 2017 and 2021, the worldwide gastroparesis medications market will grow at a CAGR of 3%. Emerging trends that will gain pace throughout the forecast period include fast-track approvals and acquisitions to change the market phase and the launch of novel techniques to treat gastroparesis symptoms. These developments will have a favorable impact on the market's expansion.

A wide number of next-generation treatment targets are now being investigated, including innovative small compounds and cellular therapy. Tofacitinib, ustekinumab, mongersen, and vedolizumab are among them. This flood is expected to occur as a result of the high frequency of gastrointestinal illnesses around the world. For Crohn's disease, vedolizumab is becoming a first-line biologic therapy. After patent expiration, branded medicines manufacturers and generic drug producers are working to produce generic drugs, which are projected to promote generics' growth. Furthermore, as the number of off-patent pharmaceuticals on the market grows, large companies are increasingly focusing on developing generics.

Below mentioned are the major players in the GI drug market:

Abb Vie Inc. (US), Astra Zeneca (UK), Johnson &Johnson (US), Valeant (US), Abbott Laboratories (US), Allergan PLC (US), Bayer AG (Germany), Janssen Biotech Inc. (US), Takeda Pharmaceutical Company Limited (Japan), Eisai Co., Ltd. (Japan), Valeant Pharmaceuticals (US), Sanofi (France), Janssen Biotech (US), Glaxo Smith Kline PLC. (UK), Boehringer Ingelheim GmbH (Germany).

Market Analysis/About Previous Editions

We extend our sincere thanks to all our great Keynote Speakers, Speakers, Delegates, and Guests for making Gastroenterology 2019 a fruitful event.

AAC hosted the event of "2nd International Conference on Gastroenterology and Digestive Disorders" during May 23-24, 2019 in Vienna, Austria at Fleming’s Conference Hotel Wien

Talks and discussions focused on the theme "Exploring the futuristic innovations and Praxis to enrich Gastro Health", and it was an astounding success where prominent keynote speakers from different reputed associations and universities made their vivid nearness and tended to the social affair.

AAC wants to pass on a heartfelt appreciation to the Session Chairs/ Co-Chairs and Session Speakers who made this meeting more valuable and effective to the Researchers, Educators, Investigate Researchers, and Delegates from the Healthcare parts gathered there.

Gastroenterology 2019 Conference was specifically planned with a uniting axiom providing the platform to expand the imminent scientific creations.

The features of the meeting were the edifying Keynote addresses from:

Wassil Nowicky | Gastrointestinal Anti -Cancer Institute | Austria

Vinod Nikhra | Hindu Rao Hospital | New Delhi

Werner Scheithauer | Medical University | Vienna

Olena Grechanina | Kharkiv Medical Academy of Post-graduate Education | Ukraine

Michael J. Powel | DiaCarta, Inc | USA

With the impressive success of Gastroenterology 2019, AAC is pleased to announce the "3rd International Conference on Gastroenterology and Digestive Disorders” which is scheduled to be held during December 18, 2021 | Webinar